Cited by 229Retinal Development and DisordersRetinal Diseases and TreatmentsRetinoids in leukemia and cellular processes

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration

Open access

Radu, Roxana A., Mata, Nathan L., Nusinowitz, Steven, Liu, Xinran, Sieving, Paul A., Travis, Gabriel H.·2003·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0737855100PMC PMC153626

Open this paper in CoChat — free account

Abstract

Recessive Stargardt's macular degeneration is an inherited blinding disease of children caused by mutations in the ABCR gene. The primary pathologic defect in Stargardt's disease is accumulation of toxic lipofuscin pigments such as N -retinylidene- N -retinylethanolamine (A2E) in cells of the retinal pigment epithelium. This accumulation appears to be responsible for the photoreceptor death and severe visual loss in Stargardt's patients. Here, we tested a therapeutic strategy to inhibit lipofuscin accumulation in a mouse model of recessive Stargardt's disease. Isotretinoin (Accutane) has been shown to slow the synthesis of 11- cis -retinaldehyde and regeneration of rhodopsin by inhibiting 11- cis -retinol dehydrogenase in the visual cycle. Light activation of rhodopsin results in its release of all-trans -retinaldehyde, which constitutes the first reactant in A2E biosynthesis. Accordingly, we tested the effects of isotretinoin on lipofuscin accumulation in abcr −/− knockout mice. Isotretinoin blocked the formation of A2E biochemically and the accumulation of lipofuscin pigments by electron microscopy. We observed no significant visual loss in treated abcr −/− mice by electroretinography. Isotretinoin also blocked the slower, age-dependent accumulation of lipofuscin in wild-type mice. These results corroborate the proposed mechanism of A2E biogenesis. Further, they suggest that treatment with isotretinoin may inhibit lipofuscin accumulation and thus delay the onset of visual loss in Stargardt's patients. Finally, the results suggest that isotretinoin may be an effective treatment for other forms of retinal or macular degeneration associated with lipofuscin accumulation.

Integrity signals

Registry

Crossref · 10.1073/pnas.0737855100

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Prevalence of age-related maculopathy
Klein, R., Klein, B. E. K., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31871-8 · Cited by 1,845
The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.
Leibowitz, H. M., Krueger, D. E., Maunder, L. R., Milton, R. C., KINI, M. M., Kahn, H. A., Nickerson, R. J., Pool, J., Colton, T., Ganley, J. P., et al. (1980) · PubMed · Cited by 1,250
Insights into the Function of Rim Protein in Photoreceptors and Etiology of Stargardt's Disease from the Phenotype in abcr Knockout Mice
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881
Self-citation
Mutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular Degeneration
Allikmets, R. L., Shroyer, N. F., Singh, N., Seddon, J. M., Lewis, R. A., Bernstein, P. S., Peiffer, A. P., Zabriskie, N. A., Li, Y., Hutchinson, A. A., et al. (1997) · Science · doi:10.1126/science.277.5333.1805 · Cited by 879
Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic Acid
Peck, G. L., Olsen, T. G., Yoder, F. W., Strauss, J. S., Downing, D. T., Pandya, M. D., Butkus, D., & ARNAUD‐BATTANDIER, J. (1979) · New England Journal of Medicine · doi:10.1056/nejm197902153000701 · Cited by 519
Isolation and one-step preparation of A2E and iso -A2E, fluorophores from human retinal pigment epithelium
Parish, C. A., Hashimoto, M., Nakanishi, K., Dillon, J., & Sparrow, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14609 · Cited by 474
Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR -mediated retinal and macular degeneration
Mata, N. L., Weng, J., & Travis, G. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130110497 · Cited by 456
Self-citation
Isomerization and Oxidation of Vitamin A in Cone-Dominant Retinas
Mata, N. L., Radu, R. A., Clemmons, R. S., & Travis, G. H. (2002) · Neuron · doi:10.1016/s0896-6273(02)00912-1 · Cited by 382
Self-citation
Retinal Stimulates ATP Hydrolysis by Purified and Reconstituted ABCR, the Photoreceptor-specific ATP-binding Cassette Transporter Responsible for Stargardt Disease
Sun, H., Molday, R. S., & Nathans, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8269 · Cited by 353

Flagged first, then by citations

Show all 43 references

1 of the 43 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

P A Blacharski Fundus flavimaculutus (Raven, New York, 1988).
N L Mata, R T Tzekov, X R Liu, J Weng, D G Birch, G H Travis Invest Ophthalmol Visual Sci 42, 1685–1690 (2001).
F Schutt, S Davies, J Kopitz, F G Holz, M E Boulton Invest Ophthalmol Visual Sci 41, 2203–2208 (2000).
J R Sparrow, J Zhou, S Ben-Shabat, H Vollmer, Y Itagaki, K Nakanishi Invest Ophthalmol Visual Sci 43, 1222–1227 (2002).
D C Hood, D G Birch Invest Ophthalmol Visual Sci 31, 2070–2081 (1990).

Sorted by citations

Items 101–200 of 229

The challenge of modeling macular degeneration in mice
Marmorstein, A. D., & Marmorstein, L. Y. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.03.001 · Cited by 46
Deep learning segmentation of hyperautofluorescent fleck lesions in Stargardt disease
Charng, J., Xiao, D., Mehdizadeh, M., Attia, M. S., Arunachalam, S., Lamey, T. M., Thompson, J. A., McLaren, T. L., Roach, J. N. D., Mackey, D. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73339-y · Cited by 43
Unraveling A Complex Genetic Disease: Age-related Macular Degeneration
Chamberlain, M., Baird, P. N., Dirani, M., & Guymer, R. H. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.08.003 · Cited by 42
Gene Therapy for Inherited Retinal Diseases: From Laboratory Bench to Patient Bedside and Beyond
Brar, A. S., Parameswarappa, D. C., Takkar, B., Narayanan, R., Jalali, S., Mandal, S., Fujinami, K., & Padhy, S. K. (2023) · Ophthalmology and Therapy · doi:10.1007/s40123-023-00862-2 · Cited by 43
The 5HT1a Receptor Agonist 8-Oh DPAT Induces Protection from Lipofuscin Accumulation and Oxidative Stress in the Retinal Pigment Epithelium
Thampi, P., Rao, H. V., Mitter, S. K., Cai, J., Mao, H., Li, H., Seo, S., Qi, X., Lewin, A. S., Romano, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034468 · Cited by 40
A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle
Rácz, B., Váradi, A., Kong, J., Allikmets, R. L., Pearson, P. G., Johnson, G., Cioffi, C. L., & Petrukhin, K. E. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002062 · Cited by 40
Treatment of Dry Age-Related Macular Degeneration
Querques, G., Rosenfeld, P. J., Cavallero, E., Borrelli, E., Corvi, F., Querques, L., Bandello, F. M., & Zarbin, M. A. (2014) · Ophthalmic Research · doi:10.1159/000363187 · Cited by 39
Stargardt's Disease and the ABCR Gene
Westerfeld, C. B., & Mukai, S. (2008) · Seminars in Ophthalmology · doi:10.1080/08820530701745249 · Cited by 39
Molecular Testing for Hereditary Retinal Disease as Part of Clinical Care
Downs, K. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.2.252 · Cited by 39
Interphotoreceptor Retinoid-Binding Protein (IRBP) in Retinal Health and Disease
Zeng, S., Zhang, T., Madigan, M. C., Fernando, N., Aggio-Bruce, R., Zhou, F., Pierce, M., Chen, Y., Huang, L., Natoli, R., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.577935 · Cited by 37
“Lipofuscin is also responsible for retinal autofluorescence in retinal diseases (Birnbach et al., 1994; Marmorstein et al., 2002; Radu et al., 2003).”
Background
Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment
Petrukhin, K. E. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.05.004 · Cited by 39
Statistically strong label-free quantitative identification of native fluorophores in a biological sample
Mahbub, S. B., Plöschner, M., Gosnell, M. E., Anwer, A. G., & Goldys, E. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-15952-y · Cited by 37
Bicyclic [3.3.0]-Octahydrocyclopenta[ c ]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease
Cioffi, C. L., Rácz, B., Freeman, E. E., Conlon, M. P., Chen, P., Stafford, D. G., Schwarz, D. M. C., Zhu, L., Kitchen, D. B., Barnes, K. D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00423 · Cited by 36
Melanization and phagocytosis: implications for age related macular degeneration.
Sarangarajan, R., & Apte, S. (2005) · PubMed · Cited by 35
Protective effects of myricetin and related flavonols against A2E and light mediated-cell death in bovine retinal primary cell culture
Laabich, A., Manmoto, C. C., Kuksa, V., Leung, D. W., Vissvesvaran, G. P., Karliga, I., Kamat, M., Scott, I. L., Fawzi, A. B., & Kubota, R. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.04.003 · Cited by 35
Therapy for macular degeneration: Insights from acne
Sparrow, J. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031478100 · Cited by 35
Protective effects of resveratrol and its analogs on age-related macular degeneration in vitro
Kang, J.-H., & Choung, S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0839-0 · Cited by 34
Scanning Laser Ophthalmoscope Measurement of Local Fundus Reflectance and Autofluorescence Changes Arising from Rhodopsin Bleaching and Regeneration
Morgan, J. I. W., & Pugh, E. N. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11089 · Cited by 33
Treatment of retinal and choroidal degenerations and dystrophies: current status and prospects for gene-based therapy
Weleber, R. G., Kurz, D. E., & Trzupek, K. M. (2003) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(03)00072-5 · Cited by 32
Characterization of Dihydro-A2PE: An Intermediate in the A2E Biosynthetic Pathway
Kim, S. R., He, J., Yanase, E., Jang, Y. P., Berova, N. D., Sparrow, J. R., & Nakanishi, K. (2007) · Biochemistry · doi:10.1021/bi7009635 · Cited by 32
Effective gene therapy of Stargardt disease with PEG-ECO/pGRK1-ABCA4-S/MAR nanoparticles
Sun, D., Sun, W., Gao, S., Lehrer, J., Naderi, A., Wei, C., Lee, S.-J., Schilb, A. L., Scheidt, J. H., Hall, R. C. W., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.026 · Cited by 31
Retinal Histopathology in Eyes from a Patient with Stargardt disease caused by Compound Heterozygous ABCA4 Mutations
Bonilha, V. L., Rayborn, M. E., Bell, B. A., Marino, M. J., Fishman, G. A., & Hollyfield, J. G. (2014) · Ophthalmic Genetics · doi:10.3109/13816810.2014.958861 · Cited by 29
Potential Therapeutic Agents Against Retinal Diseases Caused by Aberrant Metabolism of Retinoids
Liu, X., Chen, J., Liu, Z., Li, J., Yao, K., & Wu, Y. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18429 · Cited by 30
Self-citation
Juvenile Macular Degenerations
Altschwager, P., Ambrosio, L., Swanson, E. A., Moskowitz, A., & Fulton, A. B. (2017) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2017.05.005 · Cited by 29
Retinitis Pigmentosa and Allied Disorders
Weleber, R. G., & Gregory-Evans, K. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02598-0.50023-9 · Cited by 30
Inherited multifocal RPE-diseases: mechanisms for local dysfunction in global retinoid cycle gene defects
Besch, D., Jägle, H., Scholl, H. P. N., Seeliger, M. W., & Zrenner, E. (2003) · Vision Research · doi:10.1016/j.visres.2003.09.020 · Cited by 28
Functional trade-offs and environmental variation shaped ancient trajectories in the evolution of dim-light vision
Castiglione, G. M., & Chang, B. S. W. (2018) · eLife · doi:10.7554/elife.35957 · Cited by 27
Severe autosomal recessive retinitis pigmentosa maps to chromosome 1p13.3–p21.2 between D1S2896 and D1S457 but outside ABCA4
Zhang, Q., Zulfiqar, F., Xiao, X., Riazuddin, S., Ayyagari, R., Sabar, F., Caruso, R., Sieving, P. A., Riazuddin, S., & Hejtmancik, J. F. (2005) · Human Genetics · doi:10.1007/s00439-005-0054-4 · Cited by 28
Self-citation
Effects of Long-Term Administration of 9-cis-Retinyl Acetate on Visual Function in Mice
Maeda, T., Maeda, A., Leahy, P., Saperstein, D. A., & Palczewski, K. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2301 · Cited by 27
Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse model
Sun, D., Sun, W., Gao, S., Wei, C., Naderi, A., Schilb, A. L., Scheidt, J. H., Lee, S. J., Kern, T. S., Palczewski, K., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.010 · Cited by 27
Pharmacologic treatment of atrophic age-related macular degeneration
Mata, N. L., & Vogel, R. (2010) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32833866c8 · Cited by 26
Self-citation
Multiple A2E treatments lead to melanization of rod outer segment-challenged ARPE-19 cells.
Poliakov, E., Strunnikova, N. V., Jiang, J., Martinez, B., Parikh, T. P., Lakkaraju, A., Thomas, C. J., Brooks, B. P., & Redmond, T. M. (2014) · Europe PMC (PubMed Central) · Cited by 27
Omega-3 Fatty Acids Supplementation: Therapeutic Potential in a Mouse Model of Stargardt Disease
Prokopiou, E., Kolovos, P., Kalogerou, M., Neokleous, A., Nicolaou, O., Sokratous, K., Kyriacou, K. C., & Georgiou, T. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23523 · Cited by 27
Emerging Therapeutic Approaches and Genetic Insights in Stargardt Disease: A Comprehensive Review
Ghenciu, L. A., Hațegan, O. A., Stoicescu, E. R., Iacob, R., & Șișu, A. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168859 · Cited by 29
Penetration, distribution, and elimination of remofuscin/soraprazan in Stargardt mouse eyes following a single intravitreal injection using pharmacokinetics and transmission electron microscopic autoradiography: Implication for the local treatment of Stargardt’s disease and dry age‐related macular degeneration
Julien, S., Illing, B., Tschulakow, A., Taubitz, T., Guezguez, J., Burnet, M. W. M., & Schraermeyer, U. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.683 · Cited by 25
A vicious cycle of bisretinoid formation and oxidation relevant to recessive Stargardt disease
Zhao, J., Kim, H. J., Ueda, K., Zhang, K., Montenegro, D., Dunaief, J. L., & Sparrow, J. R. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100259 · Cited by 25
Can Vitamin A be Improved to Prevent Blindness due to Age-Related Macular Degeneration, Stargardt Disease and Other Retinal Dystrophies?
Saad, L., & Washington, I. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_47 · Cited by 27
Highly sensitive measurements of disease progression in rare disorders: Developing and validating a multimodal model of retinal degeneration in Stargardt disease
Lambertus, S., Bax, N. M., Fakin, A., Groenewoud, J. M. M., Klevering, B. J., Moore, A. T., Michaelides, M., Webster, A. R., van der Wilt, G. J., & Hoyng, C. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174020 · Cited by 23
Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo
Fontaine, V. K., Monteiro, E., Brazhnikova, E., Lesage, L., Balducci, C., Guibout, L., Feraille, L., Elena, P.-P., Sahel, J., Veillet, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167793 · Cited by 24
The Clinical Application of Ozonetherapy
Bocci, V. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-9234-2_9 · Cited by 24
A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration
Shin, Y., Moiseyev, G. P., Petrukhin, K. E., Cioffi, C. L., Muthuraman, P., Takahashi, Y., & Ma, J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.014 · Cited by 24
Monitoring and Management of the Patient with Stargardt Disease
Cicinelli, M. V., Battista, M., Starace, V., Parodi, M. B., & Bandello, F. M. (2019) · Clinical Optometry · doi:10.2147/opto.s226595 · Cited by 22
Suppressive Effect of Arctium Lappa L. Leaves on Retinal Damage Against A2E-Induced ARPE-19 Cells and Mice
Kim, D., Choi, Y. R., Shim, J., Choi, Y., Kim, Y. T., Kim, M. K., & Kim, M. J. (2020) · Molecules · doi:10.3390/molecules25071737 · Cited by 20
Lipofuscin of the Retinal Pigment Epithelium
(2007) · Springer eBooks · doi:10.1007/978-3-540-71994-6_1 · Cited by 20
Novel mutations in RDH5 cause fundus albipunctatus in two consanguineous Pakistani families.
Ajmal, M., Khan, M. I., Neveling, K., Khan, Y. M., Ali, S. H. B., Ahmed, W., Iqbal, M. S., Azam, M., den Hollander, A. I., Collin, R. W. J., et al. (2012) · Europe PMC (PubMed Central) · Cited by 19
Pharmacotherapy for metabolic and cellular stress in degenerative retinal diseases
Kubota, R., Gregory, J. K., Henry, S., & Mata, N. L. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.11.013 · Cited by 19
Self-citation
Towards a New Biomarker for Diabetic Retinopathy: Exploring RBP3 Structure and Retinoids Binding for Functional Imaging of Eyes In Vivo
Kaushik, V., Gessa, L., Kumar, N., & Fernandes, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054408 · Cited by 22
Retinal degeneration in animal models with a defective visual cycle
Maeda, A., & Palczewski, K. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2014.01.001 · Cited by 19
Retinol dehydrogenase 8 and ATP‐binding cassette transporter 4 modulate dark adaptation of M‐cones in mammalian retina
Kolesnikov, A. V., Maeda, A., Tang, P. H., Imanishi, Y., Palczewski, K., & Kefalov, V. J. (2015) · The Journal of Physiology · doi:10.1113/jp271285 · Cited by 20
Light Filtering in a Retinal Pigment Epithelial Cell Culture Model
Zhou, J., & Sparrow, J. R. (2011) · Optometry and Vision Science · doi:10.1097/opx.0b013e3182158cdd · Cited by 18
Historical evolution in the understanding of Stargardt macular dystrophy
Fishman, G. A. (2010) · Ophthalmic Genetics · doi:10.3109/13816810.2010.499887 · Cited by 17
Seeing the light: New insights into the molecular pathogenesis of retinal diseases
Campochiaro, P. A. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21213 · Cited by 19
A Ketogenic & Low-Protein Diet Slows Retinal Degeneration in rd10 Mice
Ryals, R. C., Huang, S. J., Wafai, D., Bernert, C., Steele, W., Six, M., Bonthala, S., Titus, H. E., Yang, P. G., Gillingham, M. B., et al. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.11.18 · Cited by 16
Drug Delivery to Posterior Intraocular Tissues: Third Annual ARVO/Pfizer Ophthalmics Research Institute Conference
Edelhauser, H. F., Boatright, J. H., & Nickerson, J. M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1904 · Cited by 17
Inherited and Orphan Retinal Diseases: Phenotypes, Genotypes, and Probable Treatment Groups
Weleber, R. G. (2005) · Retina · doi:10.1097/00006982-200512001-00002 · Cited by 17
Advances and therapeutic opportunities in visual cycle modulation
Zaluski, J., Bassetto, M., Kiser, P. D., & Tochtrop, G. P. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101360 · Cited by 15
Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders
Khan, S., Wai, C., & Ho, E. A. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01756-x · Cited by 18
Human retinal dark adaptation tracked in vivo with the electroretinogram: insights into processes underlying recovery of cone‐ and rod‐mediated vision
Jiang, X., & Mahroo, O. A. (2022) · The Journal of Physiology · doi:10.1113/jp283105 · Cited by 13
Retinoid analogs and polyphenols as potential therapeutics for age-related macular degeneration
Parmar, T., Ortega, J. T., & Jastrzębska, B. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220926938 · Cited by 14
Excessive serous retinal detachment during the use of isotretinoin
Çıtırık, M., & Tekin, K. (2017) · International Ophthalmology · doi:10.1007/s10792-017-0482-x · Cited by 13
Macular Dystrophies
Sohn, E. H., Mullins, R. F., & Stone, E. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00042-4 · Cited by 13
The novel visual cycle inhibitor (±)-RPE65-61 protects retinal photoreceptors from light-induced degeneration
Wang, Y., Ma, X., Muthuraman, P., Raja, A., Jayaraman, A., Petrukhin, K. E., Cioffi, C. L., Ma, J., & Moiseyev, G. P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269437 · Cited by 13
Surrogate electroretinographic markers for assessing therapeutic efficacy in the retina
Birch, D. G. (2004) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.4.5.693 · Cited by 12
Genetic Basis of Inherited Macular Dystrophies and Implications for Stem Cell Therapy
Mellough, C., STEEL, D. H., & Lako, M. (2009) · Stem Cells · doi:10.1002/stem.159 · Cited by 12
Single doses of all-trans-N-retinylacetamide slow down the ERG amplitude recovery after bleaching in rats
Messias, A. M. V., Zrenner, E., Tzekov, R. T., McGee, D. H., Peters, T. M., Wilhelm, B., Baryluk, A., Kubota, R., & Gekeler, F. (2009) · Documenta Ophthalmologica · doi:10.1007/s10633-009-9209-2 · Cited by 10
Visual Cycle Suppression via Patching in Central Serous Chorioretinopathy
Earl, J. B., Lee, C. S., Yom, V. H., Stavern, G. P. V., Abuattieh, M., Chin-Yee, D., Rao, P. K., & Apte, R. S. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.06.038 · Cited by 10
Pharmacotherapy of Age-Related Macular Degeneration
Blumenkranz, M., Leung, L., Martin, D. F., Rosenfeld, P., & Zarbin, M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00067-9 · Cited by 8
Visual Transduction and Age-Related Changes in Lipofuscin
RóŻanowski, M., & Różanowski, B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-374-5_20 · Cited by 11
Structures and biogenetic analysis of lipofuscin bis-retinoids
Wu, Y., Li, J., & Yao, K. (2013) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1300051 · Cited by 9
Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey
Rácz, B., Váradi, A., Pearson, P. G., & Petrukhin, K. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228291 · Cited by 9
Stargardt Disease
Allikmets, R. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-186-4_5 · Cited by 9
Evaluation of 4-Methylpyrazole as a Potential Therapeutic Dark Adaptation Inhibitor
Jurgensmeier, C. D., Bhosale, P., & Bernstein, P. S. (2007) · Current Eye Research · doi:10.1080/02713680701616156 · Cited by 9
Structure and Function of Rod and Cone Photoreceptors
Chen, J., & Sampath, A. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00014-x · Cited by 9
Current and future therapies for age-related macular degeneration
Beutel, J., Rudolf, M., & Grisanti, S. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902824141 · Cited by 9
Rationale for an experimental treatment of retinitis pigmentosa: 140-Month test of hypothesis with one patient
Baumgartner, W. A., & Baumgartner, A. M. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.07.036 · Cited by 8
Test-Retest Reliability and Inter-Ocular Symmetry of Multi-Focal Electroretinography in Stargardt Disease
Tosha, C., Gorin, M. B., & Nusinowitz, S. (2009) · Current Eye Research · doi:10.3109/02713680903374224 · Cited by 8
Self-citation
Intravitreal Delivery of PEGylated-ECO Plasmid DNA Nanoparticles for Gene Therapy of Stargardt Disease
Sun, D., Sun, W., Gao, S., Lehrer, J., Wang, H., Hall, R. C. W., & Lu, Z. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03679-1 · Cited by 7
The role of multimodal imaging and vision function testing in ABCA4 -related retinopathies and their relevance to future therapeutic interventions
Al‐Khuzaei, S., Shah, M., Foster, C. R., Yu, J., Broadgate, S., Halford, S., & Downes, S. M. (2021) · Therapeutic Advances in Ophthalmology · doi:10.1177/25158414211056384 · Cited by 7
Vitamin A aldehyde-taurine adducts function in photoreceptor cells
Kim, H. J., Zhao, J., & Sparrow, J. R. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102386 · Cited by 7
Current Insights into Targeting Strategies for the Effective Therapy of Diseases of the Posterior Eye Segment
Pimple, P. M., Sawant, A., Nair, S., & Sawarkar, S. P. (2023) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2023044057 · Cited by 6
Recent Developments in Agents for the Treatment of Age-Related Macular Degeneration and Stargardt Disease
Petrukhin, K. E. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2020_105 · Cited by 6
A method for noninvasive studying tissue disorders in type 2 diabetes mellitus in db/db mice using laser Doppler flowmetry
Степанова, О. И., Алексеевич, К. Р., Семёнов, Х. Х., Анатольевич, П. И., Онищенко, Н. А., & Каркищенко, В. Н. (2023) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2023.02.118-129 · Cited by 6
Structure and Function of Rod Photoreceptors
Chen, J., Geller, S. F., & Flannery, J. G. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02598-0.50014-8 · Cited by 6
Retinal Hereditary and Degenerative/Dystrophic Diseases (Non-Age-Related Macular Degeneration)
Parodi, M. B., Spina, C. L., Corradetti, G., Berchicci, L., Petruzzi, G., & Bandello, F. M. (2015) · Developments in ophthalmology · doi:10.1159/000431125 · Cited by 6
Pathogenetic Mechanisms in Age-Related Macular Degeneration
Bird, A. C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00064-3 · Cited by 5
Impacts of deletion and ichthyosis prematurity syndrome‐associated mutations in fatty acid transport protein 4 on the function of RPE65
Li, S., Green, J. F., & Jin, M. (2019) · FEBS Letters · doi:10.1002/1873-3468.13633 · Cited by 5
Beyond Basic Research for Inherited and Orphan Retinal Diseases: Successes and Challenges
Chader, G. J. (2005) · Retina · doi:10.1097/00006982-200512001-00006 · Cited by 5
Childhood macular dystrophies
Moore, A. T. (2009) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32832f8002 · Cited by 5
RPE Lipofuscin
Sparrow, J. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-186-4_12 · Cited by 5
HTRA1-dependent proteolysis induces age-related retinal degeneration and exacerbates choroidal neovascularization
Katschke, K. J., Truong, T., Pham, V. C., Xi, H., Tang, W., Gu, X., Teotia, P., Hofmann, J. W., Chaney, S. Y., Kirchhofer, D., et al. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052253 · Cited by 4
UPDATE ON THE GENETICS OF MACULAR DYSTROPHIES
Voo, I., & Small, K. W. (2004) · Retina · doi:10.1097/00006982-200408000-00013 · Cited by 4
Cross-sectional assessment of the ellipsoid zone and the retinal pigment epithelium-Bruch membrane complex after systemic isotretinotin use
Işık, İ. G., & Işık, M. U. (2022) · Cutaneous and Ocular Toxicology · doi:10.1080/15569527.2021.2025386 · Cited by 3
Identification of genetic variation and haplotype structure of the canine ABCA4 gene for retinal disease association studies
Zangerl, B., Lindauer, S. J., Acland, G. M., & Aguirre, G. K. (2010) · Molecular Genetics and Genomics · doi:10.1007/s00438-010-0560-5 · Cited by 3
Pathogénie des lésions de la dégénérescence maculaire liée à l’âge à un stade avancé
Bird, A. C. (2005) · Journal Français d Ophtalmologie · doi:10.1016/s0181-5512(05)81128-3 · Cited by 3
Review of Emerging Treatments for Age-Related Macular Degeneration
Zarbin, M. A., & Rosenfeld, P. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_1 · Cited by 3
Rescue of the Stargardt Disease Phenotype in Abca4 Knockout Mice Through Dietary Modulation of the Vitamin A Receptor RBPR2
Radhakrishnan, R., Leung, M., Yochim, D., Roehrich, H., McPherson, S. W., & Lobo, G. P. (2025) · FASEB BioAdvances · doi:10.1096/fba.2025-00173 · Cited by 3
New possibilities in the treatment of Stargardt disease
Zhorzholadze, N. V., Sheremet, N. L., Tanas, A. S., & Strelnikov, V. V. (2020) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2020136042333 · Cited by 3
Genetics of Age-Related Maculopathy
Fafowora, O. F., & Gorin, M. B. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780195326147.003.0037 · Cited by 2
Effect of central serous chorioretinopathy patients by covering sick eye for 48 hours
Zhao, H., Qiu, C., Shi, Y., Zhang, Y., Nie, C., Gong, Y., Zhao, J., & Luo, L. (2021) · Arquivos Brasileiros de Oftalmologia · doi:10.5935/0004-2749.20220011 · Cited by 2
Effects of organic solvents on two retinal pigment epithelial lipofuscin fluorophores, A2E and all-trans-retinal dimer
Jin, Q., Dong, X., Chen, J., Yao, K., & Wu, Y. (2014) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1300194 · Cited by 2

Authors: Radu, R. A., Mata, N. L., Nusinowitz, S., Liu, X., Sieving, P. A., & Travis, G. H.
Affiliations: National Institutes of Health (US)
ORCID: Radu, Roxana A.
Liu, Xinran
Sieving, Paul A.
Travis, Gabriel H.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2003-04
Volume: 100
Issue: 8
Pages: 4742-4747
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0737855100
PMC: PMC153626
OpenAlex: W2127150613
Cited by: 227
References: 43
Citations by year: 2026: 3 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 11 · 2019: 5 · 2018: 8 · 2017: 6 · 2016: 8 · 2015: 13 · 2014: 11 · 2013: 8 · 2012: 14
FWCI: 5.30
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords: isotretinoin, lipofuscin accumulation, A2E, retinal pigment epithelium, visual cycle, rhodopsin regeneration
MeSH terms: Animals, Dark Adaptation, Disease Models, Animal, Genes, Recessive, Humans, Lipofuscin, Macular Degeneration, Microscopy, Electron, Models, Biological, Pigment Epithelium of Eye, Pyridinium Compounds, Retinal Pigments, Retinoids, Rod Cell Outer Segment, Isotretinoin, Mice, Knockout, ATP-Binding Cassette Transporters, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks